ABSTRACT
OBJECTIVES: to measure quality of life in patients with intermittent claudication and evaluate the ability of patients and vascular surgeons to make a similar assessment. DESIGN, MATERIALS AND METHODS: in this prospective study patients with intermittent claudication attending two vascular clinics were asked to complete a generic health-related quality of life instrument (MOS SF-36). Patient quality of life and vascular surgeons' assessment of patient quality of life were further evaluated using a single question/adjectival scale response combination. RESULTS: patients' self-assessment of their quality of life correlated better with the SF-36 score than did the surgeons' assessment. There was little correlation between the surgeons' and patients' own assessment of quality of life. The surgeons differed significantly from each other in their assessments. Claudicants had lower SF-36 scores than population norms in pain and physical aspects of quality of life. CONCLUSIONS: claudicants have worse quality of life than the general population, with pain and physical limitations being the most important domains. Surgeons predict the quality of life of claudicating patients less accurately than patients do themselves, and may differ from their colleagues in such assessments. Objective quality of life assessment in claudicants should be undertaken before treatment is decided.
Subject(s)
Intermittent Claudication/diagnosis , Quality of Life , Adult , Aged , Female , Humans , Intermittent Claudication/physiopathology , Male , Middle Aged , Patient Participation , Prospective Studies , Reproducibility of Results , Sensitivity and Specificity , Severity of Illness Index , Sickness Impact Profile , Surveys and QuestionnairesABSTRACT
OBJECTIVE: To study, by literature review, the management of subclavian-axillary vein thrombosis (SAVT) and to make recommendations. DATA SOURCES: The MEDLINE database and cross-referenced articles. STUDY SELECTION: Key words subclavian-axillary vein thrombosis, venous thrombosis, Paget-Schroetter syndrome, anticoagulation, and thrombolysis were used to extract articles related to SAVT. DATA EXTRACTION: Independent extraction of articles by 2 observers. DATA SYNTHESIS: Although numerous studies are available in the literature, they vary widely in their patient selection, treatment methods, follow-up and conclusions. As such, the management of patients with SAVT remains controversial. CONCLUSIONS: Anticoagulation remains the initial treatment of choice for acute SAVT although there is definitely a role for thrombolysis and surgery in selected cases. Surgical intervention should be reserved for patients in whom there is a specific indication. Since chronic symptoms depend largely on the etiology of the disease, treatment should be tailored to address the causative factors. A multicentre, prospective study is necessary to evaluate the optimum management strategies for patients with SAVT.
Subject(s)
Axillary Vein , Subclavian Vein , Thrombosis/therapy , Anticoagulants/therapeutic use , Humans , Thrombectomy , Thrombolytic TherapyABSTRACT
OBJECTIVE: To assess the value of intra-arterial urokinase infusion in the management of acute, critical ischemia of the lower limb. DESIGN: A prospective study. SETTING: A vascular surgery department within a university hospital. PATIENTS: Twenty-five consecutive patients with acute, critical ischemia of the lower limb, excluding those requiring immediate surgical intervention. Follow-up ranged from 1 to 18 months. INTERVENTION: Angiography followed by intra-arterial infusion of urokinase. MAIN OUTCOME MEASURES: Angiographic and clinical evidence of clot lysis and limb reperfusion, any surgical procedures required and final clinical outcome. RESULTS: Urokinase was technically successful in lysing clot in 19 patients: 7 required no further treatment; in 8 an underlying lesion was identified and repaired by either percutaneous angioplasty or surgery; in the remaining 4 patients, although the clot was lysed, the limbs remained ischemic and, since reconstruction was considered impossible, amputation was required. Two patients improved clinically with little angiographic evidence of clot lysis. A total of nine patients required amputation, seven of these as a "primary" procedure after urokinase infusion. There were four episodes of significant morbidity but no deaths. CONCLUSION: Urokinase has a place in the management of acute vascular occlusion of the lower limb, not only in treating the occlusion but, equally importantly, in facilitating identification of lesions that require surgical intervention.
Subject(s)
Ischemia/drug therapy , Leg/blood supply , Thrombolytic Therapy , Urokinase-Type Plasminogen Activator/administration & dosage , Acute Disease , Aged , Aged, 80 and over , Amputation, Surgical , Angiography , Female , Humans , Infusions, Intra-Arterial , Ischemia/diagnostic imaging , Ischemia/surgery , Male , Middle Aged , Prospective Studies , Treatment OutcomeABSTRACT
During a 15-year period, 17 patients with psoriatic arthritis had 27 foot and ankle operations. The most common operation was forefoot arthroplasty. The stage of psoriatic skin involvement and the pattern of radiographic changes in the foot and ankle joints were evaluated, and the factors thought to influence perioperative outcome were reviewed. The complications were Koebner's phenomenon (or isomorphic response), infection, and nonunion, which were uncommon. The features predicting outcome of diagnosis and treatment were not identified.
